Pustular Secondary Cutaneous Aspergillosis in an Immunosuppressed Patient.

[1]  G. Elgart,et al.  Cutaneous aspergillosis masquerading as Sweet's syndrome in a patient with acute myelogenous leukemia , 2013, Journal of cutaneous pathology.

[2]  A. Bonifaz,et al.  Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  S. Raza,et al.  Cutaneous aspergillosis as a first manifestation of systemic infection in allogeneic haematopoietic stem cell transplantation. , 2007, JPMA. The Journal of the Pakistan Medical Association.

[4]  J. Ring,et al.  Nodular erythema as early sign of systemic aspergillosis , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  J. Donnelly,et al.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. , 2004, The Lancet. Infectious diseases.

[6]  A. Ullmann.  Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole , 2003, Current medical research and opinion.

[7]  M. Estefanía,et al.  Aspergilosis cutánea secundaria en paciente inmunodeprimido , 2002 .

[8]  W. Siegert,et al.  Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation , 2001, Bone Marrow Transplantation.

[9]  Galimberti,et al.  Cutaneous aspergillosis: a report of six cases , 1998, The British journal of dermatology.